An Innovation 10 Years in the Making: The Stories in the Pages of <i>ACS Medicinal Chemistry Letters</i>-Reference-Cited by-同舟云学术

An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters

Published:2022-02-03 Issue:4 Volume:13 Page:540-545
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Altman Ryan A.¹^ORCID,Brai Annalaura²^ORCID,Golden Jennifer³^ORCID,La Regina Giuseppe⁴^ORCID,Li Zhengqiu⁵^ORCID,Moore Terry W.⁶^ORCID,Pomerantz William C. K.⁷^ORCID,Rajapaksa Naomi S.⁸^ORCID,Adams Ashley M.⁹^ORCID

Affiliation:

1. Department of Medicinal Chemistry and Molecular Pharmacology and Department of Chemistry, Purdue University, West Lafayette, Indiana 47906, United States

2. Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, Rome 00185, Italy

3. School of Pharmacy, Pharmaceutical Sciences Division, University of Wisconsin─Madison, Madison, Wisconsin 53705, United States

4. Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome, Rome 00185, Italy

5. School of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China

6. Pharmaceutical Sciences, University of Illinois at Chicago, 833 S. Wood Street, Chicago, Illinois 60612, United States

7. Department of Chemistry, University of Minnesota, 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States

8. Medicinal Chemistry, Interline Therapeutics, 620 Utah Ave, South San Francisco, California 94080, United States

9. Medicine Science and Technology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.1c00623

Reference32 articles.

1. https://axial.acs.org/2019/04/16/meet-the-acs-medicinal-chemistry-letters-early-career-board-members/.

2. Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

3. Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo

4. An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

5. Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development